Learn about Tenofovir Disoproxil Fumarate & Emtricitabine Tablets, including HIV treatment and PrEP uses, benefits, how they work, safety precautions, side effects, and FAQs.
Tenofovir Disoproxil Fumarate & Emtricitabine Tablets
Tenofovir Disoproxil Fumarate & Emtricitabine Tablets are a combination antiviral medicine containing two nucleoside/nucleotide reverse transcriptase inhibitors (NRTIs): tenofovir disoproxil fumarate (TDF) and emtricitabine (FTC).
This combination is used in specific circumstances for HIV-1 treatment as part of combination antiretroviral therapy (ART) and, in appropriate HIV-negative individuals, for pre-exposure prophylaxis (PrEP) to reduce the risk of sexually acquired HIV-1 infection. The combination also has activity against hepatitis B virus (HBV).
At Sky High Medex, pharmaceutical products are sourced and supplied subject to applicable prescription, import, export, and destination-country regulations.
Important: This is a prescription antiviral medicine. It should be taken only under appropriate medical supervision. It is not a cure for HIV, and it should not be used for HIV prevention without appropriate HIV testing and ongoing clinical monitoring.
What Are Tenofovir Disoproxil Fumarate and Emtricitabine?
The medicine contains two active antiviral ingredients:
Tenofovir Disoproxil Fumarate (TDF)
TDF is a prodrug that is converted in the body to tenofovir and then to its active form, which interferes with viral reverse transcriptase.
Emtricitabine (FTC)
Emtricitabine is another NRTI that interferes with reverse transcriptase, an enzyme HIV requires to replicate.
Using two active NRTIs together provides complementary antiviral activity and is commonly incorporated into broader HIV treatment regimens. Current HIV guidelines include TDF/FTC as an NRTI combination option in appropriate antiretroviral regimens.
What Are Tenofovir Disoproxil Fumarate & Emtricitabine Tablets Used For?
1. HIV-1 Treatment
TDF/FTC is used in combination with other antiretroviral medicines for the treatment of HIV-1 infection.
It is not generally used as the complete HIV treatment regimen by itself. A healthcare professional selects a complete ART regimen based on factors such as resistance testing, other health conditions, potential drug interactions, and individual patient needs.
Effective HIV treatment can suppress viral replication, support immune-system health, and reduce the risk of transmitting HIV to others when viral suppression is maintained.
2. HIV Pre-Exposure Prophylaxis (PrEP)
The TDF/FTC combination is also approved for PrEP in certain HIV-negative individuals at risk of acquiring HIV.
PrEP is part of a comprehensive HIV-prevention strategy and requires HIV testing before initiation and regular follow-up testing during use.
3. Activity Against Hepatitis B Virus
Both tenofovir and emtricitabine have activity against HBV. However, the TDF/FTC combination should not be treated as interchangeable with every approved hepatitis B treatment, and treatment decisions should be made by a healthcare professional.
Importantly, stopping medicines containing TDF and/or FTC in someone with HIV/HBV coinfection can lead to hepatitis B reactivation or worsening liver disease.
How Does TDF/FTC Work?
HIV uses an enzyme called reverse transcriptase to convert its viral RNA into DNA.
Tenofovir and emtricitabine are converted into active forms inside cells. These active compounds interfere with reverse transcriptase and inhibit the production of viral DNA.
By interfering with HIV replication, the medicines help reduce the amount of virus in the body when used as part of an appropriate regimen.
Potential Benefits of Tenofovir Disoproxil Fumarate & Emtricitabine
Helps Suppress HIV Replication
When combined with other effective antiretroviral medicines, TDF/FTC contributes to suppression of HIV replication.
Supports Long-Term HIV Management
Consistent adherence to an effective ART regimen can help people with HIV maintain viral suppression and protect immune-system function.
Provides an Established NRTI Combination
TDF and FTC are well-established NRTIs and have been incorporated into numerous antiretroviral treatment strategies.
Helps Reduce the Risk of Sexually Acquired HIV
For appropriately selected HIV-negative individuals, TDF/FTC used as PrEP can reduce the risk of sexually acquired HIV when taken as prescribed and combined with other prevention measures.
Has Activity Against HBV
Both active ingredients have anti-HBV activity, which can be particularly relevant when managing individuals with HIV/HBV coinfection.
TDF/FTC for HIV Treatment
For someone living with HIV, TDF/FTC is used as part of a complete antiretroviral regimen, rather than as a standalone treatment.
Modern ART regimens are selected according to individual circumstances, including:
- HIV resistance testing
- Previous antiretroviral treatment
- Kidney function
- Bone health
- Hepatitis B status
- Potential drug interactions
- Pregnancy considerations
- Other medical conditions
Current guidelines list TDF/FTC as one of the possible NRTI backbones in selected treatment regimens.
TDF/FTC for HIV PrEP
Pre-exposure prophylaxis, or PrEP, involves taking an HIV medicine before potential exposure to HIV to reduce the likelihood of infection.
For TDF/FTC PrEP:
- HIV-negative status should be confirmed before starting.
- Regular HIV testing is required during PrEP.
- The medicine must be taken according to the prescribed regimen.
- PrEP should be combined with appropriate HIV-prevention strategies.
- It does not protect against other sexually transmitted infections.
The FDA labeling specifies TDF/FTC PrEP for certain at-risk adults and adolescents weighing at least 35 kg.
Importance of Adherence
Consistent medication use is an important part of HIV treatment and PrEP.
For HIV treatment, missed doses can reduce antiviral effectiveness and may contribute to resistance in some circumstances.
For PrEP, inadequate adherence can reduce protection against HIV.
Patients should follow the prescribed schedule and discuss difficulties with adherence with their healthcare professional rather than changing the regimen independently.
Kidney and Bone Health Considerations
Tenofovir disoproxil fumarate can affect kidney function and bone mineral density in some individuals.
For this reason, healthcare professionals may assess kidney function before and during treatment, depending on the patient's circumstances.
TDF may also be less suitable for some individuals with kidney or bone-health concerns. Current HIV guidelines note that tenofovir alafenamide (TAF) generally has fewer kidney and bone toxicities than TDF, while TDF may have more favorable lipid effects.
Possible Side Effects
Potential adverse effects vary between individuals.
Some people may experience:
- Nausea
- Diarrhea
- Headache
- Abdominal discomfort
- Fatigue
- Dizziness
More important potential concerns with TDF-containing therapy include effects on kidney function and bone mineral density.
Rare but serious metabolic or liver-related complications can also occur.
Seek medical attention for severe or unusual symptoms, particularly significant weakness, persistent vomiting, breathing difficulties, severe abdominal symptoms, or signs of an allergic reaction.
Important Precautions
Before taking TDF/FTC, tell your healthcare professional if you have:
- Kidney disease
- Bone-density problems
- Hepatitis B infection
- HIV infection or possible recent HIV exposure
- Other chronic medical conditions
- A history of medication allergies
- Current prescription or non-prescription medicines
Kidney function may need to be assessed before treatment and periodically afterward.
Hepatitis B and Stopping Treatment
One of the most important considerations is hepatitis B infection.
TDF and FTC are active against HBV. If a person has HIV/HBV coinfection and stops a TDF/FTC-containing regimen without appropriate alternative HBV therapy, HBV can rebound and cause a potentially serious flare of liver disease.
Therefore, people with HBV should not stop treatment without consulting their healthcare professional.
Drug Interactions
TDF/FTC may interact with other medicines, particularly medicines that affect kidney function or other drugs with overlapping toxicities.
Always provide your healthcare professional with a complete list of:
- Prescription medicines
- Over-the-counter medicines
- Vitamins
- Herbal products
- Other antiviral medicines
Do not start or stop another medicine without checking for potential interactions.
Pregnancy and Breastfeeding
People who are pregnant, planning pregnancy, or breastfeeding should discuss TDF/FTC use with a healthcare professional.
The appropriate antiretroviral regimen depends on the individual's HIV status, treatment history, pregnancy stage, HBV status, and other clinical factors.
Storage and Handling
Follow the manufacturer's storage instructions printed on the packaging.
General precautions include:
- Keep tablets in their original container.
- Store at the recommended temperature.
- Protect the medicine from excessive heat and moisture.
- Keep the container tightly closed.
- Keep out of reach of children.
- Do not use expired tablets.
Frequently Asked Questions (FAQs)
What are Tenofovir Disoproxil Fumarate & Emtricitabine Tablets?
They are combination antiviral tablets containing two NRTIs: tenofovir disoproxil fumarate and emtricitabine.
What are TDF/FTC tablets used for?
They may be used as part of HIV-1 treatment and, in appropriate HIV-negative individuals, for PrEP to reduce the risk of sexually acquired HIV-1 infection.
Are TDF and FTC antiretroviral medicines?
Yes. Both belong to the NRTI class of antiretroviral medicines.
Can TDF/FTC cure HIV?
No. Current HIV medicines do not cure HIV. They can suppress HIV replication and help people with HIV live longer and healthier lives when taken as prescribed.
Can TDF/FTC be used alone to treat HIV?
It is not generally used as a complete HIV treatment regimen by itself. It is combined with other antiretroviral medicines as part of an appropriate ART regimen.
Is TDF/FTC used for PrEP?
Yes. TDF/FTC is an established PrEP option for certain HIV-negative people at risk of sexually acquiring HIV. HIV testing and ongoing monitoring are essential.
Does TDF/FTC protect against other sexually transmitted infections?
No. TDF/FTC PrEP is intended to reduce the risk of HIV acquisition and does not provide protection against other sexually transmitted infections.
Does TDF/FTC work against hepatitis B?
Both tenofovir and emtricitabine have activity against HBV. However, people with chronic hepatitis B require appropriate medical management and should not discontinue therapy without professional guidance.
Can TDF/FTC affect the kidneys?
Yes. Tenofovir disoproxil fumarate can affect kidney function in some people. Healthcare professionals may monitor kidney function during treatment.
Can TDF/FTC affect bones?
TDF has been associated with reductions in bone mineral density in some patients. Individual risk should be evaluated by a healthcare professional.
What happens if I miss a dose?
Follow the instructions provided by your healthcare professional or medication guide. Do not routinely double the next dose without professional advice.
Can I stop TDF/FTC suddenly?
Do not stop treatment without discussing it with your healthcare professional. This is particularly important for people with HIV/HBV coinfection because HBV may flare after discontinuation.
Is TDF/FTC available by prescription?
It is a prescription medicine in many jurisdictions. Regulatory requirements vary by country.
Does Sky High Medex supply Tenofovir Disoproxil Fumarate & Emtricitabine Tablets?
Sky High Medex can provide information regarding pharmaceutical product sourcing and availability subject to applicable prescription, import, export, and destination-country requirements.
Why Choose Sky High Medex?
Sky High Medex supports responsible pharmaceutical product sourcing and international supply while recognizing the regulatory requirements that apply to prescription antiviral medicines.
Services may include:
- Pharmaceutical product sourcing
- Wholesale procurement
- Bulk supply
- International export support
- Product documentation assistance
- Packaging support
- Customer service
Availability and supply conditions depend on product classification and destination-country regulations.
Conclusion
Tenofovir Disoproxil Fumarate & Emtricitabine Tablets combine two established NRTIs used in appropriate HIV treatment and HIV PrEP strategies. They work by interfering with viral reverse transcriptase, helping prevent HIV from efficiently replicating.
The combination also has activity against hepatitis B, making careful treatment planning especially important for people with HIV/HBV coinfection. Because TDF can affect kidney and bone health and because treatment requires appropriate HIV testing and monitoring, these tablets should be used under qualified medical supervision.
For pharmaceutical sourcing and product information, Sky High Medex supports responsible supply subject to applicable prescription, import, export, and destination-country regulations.
